Circio: Company Update - Redeye

Redeye hosts Circio's webcast in which CEO, Dr Erik Digman Wiklund, provides an overview of the latest circVec circular RNA platform in vivo data and the focused gene therapy R&D strategy. Circio's CFO, Dr Lubor Gaal, presents unaudited financial results for 2023, followed by a Q&A session.

Länk till analysen i sin helhet: https://www.redeye.se/research/995815/circio-company-update?utm_source=finwire&utm_medium=RSS